Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/02/2026 | Q4 | $93.4M | -- | -- | -$0.13 | -- |
| 11/04/2025 | Q3 | $65.6M | $83.5M | $0.43 | -$0.12 | $0.55 |
| 08/07/2025 | Q2 | $50M | $41.3M | $1.18 | -$0.14 | $1.32 |
| 05/08/2025 | Q1 | $30M | $21.8M | -$1.30 | -$1.40 | $0.10 |
| 03/03/2025 | Q4 | $38.4M | $31.7M | $1.53 | $0.80 | $0.73 |
| 11/13/2024 | Q3 | $40.1M | $43.7M | $0.01 | -$0.38 | $0.38 |
| 08/13/2024 | Q2 | $46.9M | $35.2M | -$0.80 | -$0.08 | -$0.72 |
| 05/15/2024 | Q1 | $62.2M | $51.7M | $2.68 | $0.36 | $2.31 |
| 03/28/2024 | Q4 | $52.7M | $38.9M | $0.12 | -$0.07 | $0.19 |
| 12/19/2023 | Q3 | -- | $21.7M | -$0.10 | -- | -- |
| 06/30/2023 | Q2 | -- | $20.5M | -$0.04 | -- | -- |
| 03/31/2023 | Q1 | -- | $15.6M | $0.41 | -- | -- |
| 12/31/2022 | Q4 | -- | $16.1M | -$3.31 | -- | -- |
| 09/30/2022 | Q3 | -- | $24.2M | -$0.47 | -- | -- |
| 06/30/2022 | Q2 | -- | $34.3M | -$1.94 | -- | -- |
| 03/31/2022 | Q1 | -- | $42.1M | $1.23 | -- | -- |
| 12/31/2021 | Q4 | -- | $45.9M | -$2.60 | -- | -- |
| 09/30/2021 | Q3 | -- | $40M | $0.63 | -- | -- |
| 06/30/2021 | Q2 | -- | $27.3M | -$0.13 | -- | -- |
| 03/31/2021 | Q1 | -- | $25.3M | $0.59 | -- | -- |
| 12/31/2020 | Q4 | -- | $10M | $1.08 | -- | -- |
| 09/30/2020 | Q3 | -- | $4.3M | -$0.03 | -- | -- |
| 06/30/2020 | Q2 | -- | $6.7M | $0.11 | -- | -- |
| 03/31/2020 | Q1 | -- | $9.5M | -$0.42 | -- | -- |
| 12/31/2019 | Q4 | -- | $11.3M | -$0.99 | -- | -- |
| 09/30/2019 | Q3 | -- | $20.3M | -$0.25 | -- | -- |
| 06/30/2019 | Q2 | -- | $21.1M | $1.43 | -- | -- |
| 03/31/2019 | Q1 | -- | $9.1M | -$0.48 | -- | -- |
| 12/31/2018 | Q4 | -- | $9.8M | -$5.18 | -- | -- |
| 09/30/2018 | Q3 | -- | $13.5M | -$0.53 | -- | -- |
| 06/30/2018 | Q2 | -- | $6M | -$0.23 | -- | -- |
| 03/31/2018 | Q1 | -- | $8.7M | -$0.20 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$4.86 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.75 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.60 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.76 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$2.05 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.32 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$1.98 | -- | -- |
Hut 8 Corp. reported $83.5M worth of top line sales in its most recent quarter.
Hut 8 Corp. announced earnings per share of $0.43 which represents a beat of analyst forecast a -$0.12 per share.
Hut 8 Corp. reported $23.4M that represents $0.19 per share over the last quarter.
Hut 8 Corp.'s earnings are forecast to decrease from $3.28 per share to -$0.11 per share next year representing a decrease of -99.9%.
Hut 8 Corp.'s next earnings date is March 2, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.